| | |||||||
| lung cancer | |||||||
| 新闻 | |||||||
| FDA to Review Applications for Potential Approval of Rybrevant for NSCLC Subset ... lung cancer with EGFR exon 19 deletions or L858 substitution mutations.
| |||||||
Nogueira on the Impacts of Climate Change on Cancer Care - Targeted Oncology So in another study, we show how cancer patients who are recovering from lungs cancer surgery actually had worse overall survival if there was a ...
| |||||||
| 查看更多结果 | 修改此快讯 | |||||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment